| dc.contributor.author | Kurbonova, Z.Ch. | |
| dc.contributor.author | Babadzhanova, Sh.A. | |
| dc.date.accessioned | 2023-02-25T14:47:24Z | |
| dc.date.available | 2023-02-25T14:47:24Z | |
| dc.date.issued | 2023-02 | |
| dc.identifier.issn | 2795-7624 | |
| dc.identifier.uri | http://repository.tma.uz/xmlui/handle/1/6432 | |
| dc.description.abstract | In the last 20 years, viral infectious diseases have become the most urgent problem in medicine. Severe acute respiratory syndrome (SARS-nCoV) in 2002, Ebola disease in Africa in 2014, Middle East coronavirus syndrome (MERS-CoV) in 2015, and Zika fever in 2016 can be examples [3]. The coronavirus infection caused by SARS-CoV-2 caused a pandemic, unlike previous diseases, and once again proved the need for indepth study of these diseases. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Eurasian Medical Research Periodical | en_US |
| dc.relation.ispartofseries | 17; | |
| dc.subject | polymorphism of thrombophilia genes, coronavirus infection, hemostasis system | en_US |
| dc.subject | MTHFR 1298, MTRR 66, MTHFR 677, MTR 2756 genes | en_US |
| dc.subject | homocysteine, platelet aggregation, adhesion, active partial thromboplastin time, fibrinogen, D-dimer | en_US |
| dc.title | Prognostic Significance of Thrombophilia Gene Polymorphism in Covid-19 | en_US |
| dc.type | Article | en_US |